Collin Stultz Named Co-Director and MIT Leader of Harvard-MIT Program in Health Sciences and Technologies | MIT News

0

Collin M. Stultz, Nina T. and Robert H. Rubin Professor of Medical Engineering and Science at MIT, has been named co-director of the Harvard-MIT Program in Health Sciences and Technologies (HST) and associate director of the MIT Institute for Medical Engineering and Science (IMES), starting June 1. IMES is the headquarters of HST at MIT.

Stultz is a professor of electrical engineering and computer science at MIT, a core faculty member at IMES, an HST faculty member, and a practicing cardiologist at Massachusetts General Hospital (MGH). He is also a member of the Electronics Research Laboratory, and an associate member of the Computer Science and Artificial Intelligence Laboratory (CSAIL).

Anantha P. Chandrakasan, Dean of the MIT School of Engineering and Vannevar Bush Professor of Electrical Engineering and Computer Science, welcomed the appointment, saying that “Professor Stultz’s outstanding leadership, commitment to teaching excellence and his unwavering devotion to the pursuit of advancements in human health will undoubtedly help strengthen and strengthen the missions of IMES and HST.

Stultz succeeds Emery N. Brown, who served as the first co-director of HST at MIT, following the establishment of IMES in 2012. (Wolfram Goessling is co-director of HST at Harvard University.) Brown, the Edward Hood Taplin Professor of Medical Engineering and Computational Neuroscience at MIT, will now focus on establishing a new joint center between MIT and MGH that will use the study of anesthesia to design new approaches to controlling brain states, in the aim to improve anesthesia and critical care management.

“This has been a pleasure and an honor for me to guide HST over the past 10 years,” says Brown. “I’m sure Collin will be a phenomenal co-director. He is a highly accomplished scientist, a master clinician and a committed educator.“

George Q. Daley, Dean of Harvard Medical School and HST alumnus, said, “I am delighted that the new co-director of HST is an alumnus of Harvard Medical School who has completed clinical training and practiced at our affiliated hospitals. . Dr. Stultz’s remarkable expertise in computer science and artificial intelligence will drive positive change as we reinvigorate this historic collaboration between Harvard and MIT and redefine the scope of what it means to be a physician-scientist in the 21st century.

Elazer R. Edelman, Edward J. Poitras Professor of Medical Engineering and Science and Director of IMES, also an HST alumnus, welcomed the appointment saying, “We are so excited about the future, using the Professor Stultz’s incredible vision, his legacy of accomplishment, his commitment to mentorship and his innate ability to combine excellence in science and medicine, engineering and physiology to propel us forward. Everything Professor Stultz has done spells success for him and HST. “

Goessling says he looks forward to working with Stultz in his new role. “I have known Collin from our residency days at Brigham and Women’s Hospital where we cared for patients together. I am truly excited to work collaboratively and synergistically with him to now care for our students together, to innovate our education programs, and to continue the legacy of success for HST.

Stultz received his BA magna cum laude in mathematics and philosophy from Harvard University in 1988; a doctorate in biophysics from Harvard in 1997; and a magna cum laude MD from Harvard Medical School, also in 1997. Stultz then completed an internship and residency in internal medicine, followed by a fellowship in cardiovascular medicine, at Brigham and Women’s Hospital before joining the faculty at MIT in 2004.

Stultz once said that his research focus at MIT was twofold: “the study of the little things you can’t see with the naked eye and the study of the big things you can see”, and his scientific contributions also covered a wide range of areas. length scales. As a graduate student in the lab of Martin Karplus – 2013 Nobel laureate in Chemistry – Stultz helped develop computational methods for designing ligands to flexible protein targets. As a junior faculty member at MIT, his group leveraged computational biophysics and experimental biochemistry to model disordered proteins that play important roles in human disease. More recently, his research has focused on the development and application of machine learning methods that allow healthcare providers to gain insight into patient-specific physiology, using clinical data that is routinely obtained. in clinical and outpatient settings.

Stultz is a Fellow of the American Society for Biochemistry and Molecular Biology, the Federation of American Societies for Experimental Biology, and a Fellow of the American Institute for Medical and Biomedical Engineering. He is a past recipient of an Irving M. London Teaching Award, a National Science Foundation CAREER Award, a Burroughs Wellcome Fund Career Award in the Biomedical Sciences, and he was recently a Visiting Scholar Phi Beta Kappa.

“To follow in the footsteps of such a renowned scholar as Emery Brown is daunting; however, I am extraordinarily optimistic about what HMS, HST, and MIT can accomplish in the years to come,” Stultz says. “I look forward to working with Elazer, Anantha, Wolfram, and HMS leadership to advance HST’s educational mission on the HMS campus and throughout the MIT ecosystem.”

Share.

Comments are closed.